Page last updated: 2024-11-08

pentylenetetrazole and Sleep Initiation and Maintenance Disorders

pentylenetetrazole has been researched along with Sleep Initiation and Maintenance Disorders in 1 studies

Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bum, EN1
Taiwe, GS1
Nkainsa, LA1
Moto, FC1
Seke Etet, PF1
Hiana, IR1
Bailabar, T1
Seyni, P1
Rakotonirina, A1
Rakotonirina, SV1

Other Studies

1 other study available for pentylenetetrazole and Sleep Initiation and Maintenance Disorders

ArticleYear
Validation of anticonvulsant and sedative activity of six medicinal plants.
    Epilepsy & behavior : E&B, 2009, Volume: 14, Issue:3

    Topics: Animals; Anticonvulsants; Convulsants; Diazepam; Dose-Response Relationship, Drug; Electroshock; Epi

2009